Hui Fu - Shenzhen Bioeasy Deputy Director

300942 Stock   8.79  0.31  3.66%   

Director

Hui Fu is Deputy Director of Shenzhen Bioeasy Biotechnology
Age 40
Address No. 101, Liuxian Yi Rui Biology Building, Shenzhen, China, 518101
Phone86 755 2309 5742
Webhttps://www.bioeasy.com

Shenzhen Bioeasy Management Efficiency

The company has return on total asset (ROA) of (0.0157) % which means that it has lost $0.0157 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0919) %, meaning that it generated substantial loss on money invested by shareholders. Shenzhen Bioeasy's management efficiency ratios could be used to measure how well Shenzhen Bioeasy manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Other Assets is expected to grow to about 50.3 M, whereas Total Assets are forecasted to decline to about 869.7 M.

Similar Executives

Showing other executives

DIRECTOR Age

Fangzheng JiaoPetroChina Co Ltd
61
Cunxing DuBank of China
N/A
Jiuyong YinBank of Communications
56
Fanggen LiuChina Construction Bank
N/A
Xuewen ZhangPostal Savings Bank
62
Zhang ShouchuanBank of China
N/A
Hong YaoPostal Savings Bank
58
Wanfu ZhouBank of Communications
59
Pizheng LiChina Mobile Limited
58
Fuxiao ShenPetroChina Co Ltd
54
Xuguang ZhangAgricultural Bank of
60
Li LinAgricultural Bank of
56
Ronghua LiChina Mobile Limited
58
Zhihong JiChina Construction Bank
55
Guoyu ZhengIndustrial and Commercial
57
Jingzhen LinBank of China
59
Wei WangBank of China
61
Lixin RenPetroChina Co Ltd
56
Shenzhen Bioeasy Biotechnology (300942) is traded on Shenzhen Stock Exchange in China and employs 389 people. Shenzhen Bioeasy is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Shenzhen Bioeasy Bio Leadership Team

Elected by the shareholders, the Shenzhen Bioeasy's board of directors comprises two types of representatives: Shenzhen Bioeasy inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shenzhen. The board's role is to monitor Shenzhen Bioeasy's management team and ensure that shareholders' interests are well served. Shenzhen Bioeasy's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shenzhen Bioeasy's outside directors are responsible for providing unbiased perspectives on the board's policies.
Zhaoli Xiao, Deputy Director
Wentian Li, Secretary GM
Yaqin Chi, NonIndependent Mang
Zhiying Chen, Deputy Director
Wenhao Yan, Deputy Director
Hehua Lu, GM Director
Hui Fu, Deputy Director

Shenzhen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shenzhen Bioeasy a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Shenzhen Stock

Shenzhen Bioeasy financial ratios help investors to determine whether Shenzhen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shenzhen with respect to the benefits of owning Shenzhen Bioeasy security.